Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT04592484 |
Title | A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Codiak BioSciences |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | GBR |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Honor Health | Scottsdale | Arizona | 85258 | United States | Details | |
Columbia University/CUMC | New York | New York | 10032 | United States | Details | |
University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | United States | Details | |
NEXT Oncology | San Antonio | Texas | 78229 | United States | Details | |
The Beatson West of Scotland Cancer Centre/ Gartnavel General Hospital | Glasgow | G12 0YN | United Kingdom | Details | ||
Oxford University Hospitals NHS Trust | Headington | OX3 9DU | United Kingdom | Details | ||
The Royal Marsden Hospital | London | SW3 6JJ | United Kingdom | Details | ||
The Christie NHS Foundation Trust | Manchester | M20 4BX | United Kingdom | Details |